Heinz W Pauls

This inventor holds 44 USPTO granted patents and 8 published patent applications, plus 29 CIPO patents and 13 EPO patents, primarily in Kinase Inhibitors. Top assignees: University Health Network, Affinium Pharmaceuticals, Inc., Aventis Pharmaceuticals Inc.. Active years: 1998-2025.

USPTO Granted Patents = 44 (Patent Applications = 8)

% Patents Active = 93.2

CIPO Patents = 29

EPO Patents = 13 (Patent Applications = 12)

Average Co-Inventor Count = 5.7

ph-index = 11

Forward Citations = 277(Granted Patents)

Location History:

Collegeville, PA (US) (1998 - 2001)
Oakville, CA (US) (2009)
Toronto, CA (2010)
Oakville, CA (2008 - 2024)

Company Filing History:

33 out of 311

University Health Network

patents

2 out of 33

Affinium Pharmaceuticals, Inc.

patents

2 out of 207

Aventis Pharmaceuticals Inc.

patents

4. 2 out of 22

Debiopharm International, S.a.

patents

5. 2 out of 111

Rhone-Poulenc Rorer Pharmaceuticals Inc.

patents

6. 1 out of 330

Aventis Pharma Deutschland, Gmbh

patents

7. 1 out of 23

Aventis Pharmaceuticals Products Inc.

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Cancer Treatment

TTK Inhibitor

PLK-4 Inhibitor

RIPK2 Inhibitors

Pyrazolopyrimidine Compounds

Chiral Synthesis

Fab I Inhibitors

Heterocyclic Compounds

Oxoazaheterocyclyl Compounds

N-acylpyrrolidin Derivatives

Acrylamide Derivatives

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473283 - Compounds and their use (2025-11-18),

2. 11878980 - Solid forms of TTK inhibitor (2024-01-23),

3. 11667627 - Salt and crystal forms of PLK-4 inhibitor (2023-06-06),

4. 11104681 - Solid forms of TTK inhibitor (2021-08-31),

5. 11059832 - HPK1 inhibitors and methods of using same (2021-07-13),

6. 10919886 - Salt and crystal forms of PLK-4 inhibitor (2021-02-16),

7. 10875863 - RIPK2 inhibitors and method of treating cancer with same (2020-12-29),

8. 10584130 - Solid forms of TTK inhibitor (2020-03-10),

9. 10570143 - Pyrazolopyrimidine compounds (2020-02-25),

10. 10501474 - HPK1 inhibitors and methods of using same (2019-12-10),

11. RE47731 - Kinase inhibitors and method of treating cancer with same (2019-11-18),

12. 10472353 - Salt and crystal forms of PLK-4 inhibitor (2019-11-12),

13. 10392374 - Salt and crystal forms of PLK-4 inhibitor (2019-08-27),

14. 10358436 - Kinase inhibitors and method of treating cancer (2019-07-23),

15. 10239881 - RIPK2 inhibitors and method of treating cancer with same (2019-03-26),

Title: The Innovative Mind of Heinz W Pauls

Introduction: Heinz W Pauls, a distinguished inventor hailing from Oakville, CA, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Heinz W Pauls holds several patents in the realm of renewable energy technologies, including a recent patent for a solar-powered water purification system that has the potential to revolutionize access to clean water in remote areas.

Career Highlights: With a career spanning over three decades, Heinz W Pauls has worked tirelessly to develop sustainable solutions for pressing global challenges. His work has been instrumental in advancing the fields of green technology and environmental conservation.

Collaborations: Throughout his career, Heinz W Pauls has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life. His collaborative spirit and dedication to excellence have earned him the respect of peers in the industry.

Conclusion: Heinz W Pauls' passion for innovation and commitment to creating a better world through technology make him a true pioneer in his field. His legacy will continue to inspire future generations of inventors and innovators to push the boundaries of what is possible.